Skip to Content
  • Review
  • Open Access

3 August 2025

24 Pages

Stem Cell-Derived Corneal Epithelium: Engineering Barrier Function for Ocular Surface Repair

,
,
,
,
,
and
1
Wake Forest Institute for Regenerative Medicine, School of Medicine, Wake Forest University, Winston-Salem, NC 27101, USA
2
School of Medicine, Wake Forest University, Winston-Salem, NC 27101, USA
3
Department of Biochemistry, School of Medicine, Wake Forest University, Winston-Salem, NC 27101, USA
4
Department of Ophthalmology, School of Medicine, Wake Forest University, Winston-Salem, NC 27101, USA

Abstract

The cornea, the transparent anterior window of the eye, critically refracts light and protects intraocular structures. Corneal pathologies, including trauma, infection, chemical injury, metabolic diseases, genetic conditions, and age-related degeneration, can lead to significant visual impairment. While penetrating keratoplasty or full-thickness corneal transplantation remains a standard and effective intervention for severe corneal dysfunction, limitations in donor tissue availability and the risk of immunogenic graft rejection necessitate alternative therapeutic strategies. Furthermore, for cases of isolated epithelial disfunction, a full-thickness cornea graft may not be required or effective. This review examines the potential of corneal epithelial constructs derived from autologous stem cells with functional barrier properties for corneal reconstruction and in vitro pharmacotoxicity testing. In this review, we delineate the current limitations of corneal transplantation, the advantages of stem cell-based approaches, and recent advances in generating engineered corneal epithelium. Finally, we address remaining technical challenges and propose future research directions aimed at clinical translation.

Article Metrics

Citations

Article Access Statistics

Multiple requests from the same IP address are counted as one view.